lax, My bigger point is that the label (no matter what country approves it) will become increasingly obsolete in its current form. Not right away obviously but given the off label use that is ALREADY occurring, and as the CV events are more understood there will be a general increase in earlier line use. I would bet on it.
btw, how do we get NRx/TRx reporting now? I emailed Biologics and asked if they published any such data.....silence.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.